Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseases.
Ringdén
O
O
Svenberg
P
P
Le Blanc
K
K
Mattsson
J
J
Remberger
M
M
D004305:Dose-Response Relationship, Drug; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods* / Q000401:mortality; D006801:Humans; D019653:Myeloablative Agonists / Q000627:therapeutic use; D016019:Survival Analysis; D019172:Transplantation Conditioning / Q000379:methods*
D019653:Myeloablative Agonists